蜂窝织炎和丹毒

参考文献

关键文献

Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.全文  摘要

National Institute for Health and Care Excellence. Cellulitis and erysipelas: antimicrobial prescribing. September 2019 [internet publication].全文

Clinical Resource Efficiency Support Team. Guidelines on the management of cellulitis in adults. June 2005 [internet publication].全文

参考文献

1. McCormick A, Fleming D, Charlton J; Office of Population Censuses and Surveys. Morbidity statistics from general practice: fourth national study 1991-1992. London: HMSO; 1995.

2. NHS Digital. Hospital admitted patient care activity 2018-19. September 2019 [internet publication].全文

3. Sigurdsson AF, Gudmundsson S. The etiology of bacterial cellulitis as determined by fine-needle aspiration. Scand J Infect Dis. 1989;21(5):537-42. 摘要

4. Bernard P, Bedane C, Mounier M, et al. Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol. 1989 Jun;125(6):779-82. 摘要

5. Eriksson B, Jorup-Ronstrom C, Karkkonen K, et al. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis. 1996 Nov;23(5):1091-8. 摘要

6. Lutomski DM, Trott AT, Runyon JM, et al. Microbiology of adult cellulitis. J Fam Pract. 1988 Jan;26(1):45-8. 摘要

7. Leppard BJ, Seal DV, Colman G, et al. The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. Br J Dermatol. 1985 May;112(5):559-67. 摘要

8. Kielhofner MA, Brown B, Dall L. Influence of underlying disease process on the utility of cellulitis needle aspirates. Arch Intern Med. 1988 Nov;148(11):2451-2. 摘要

9. Bernard P, Toty L, Mounier M, et al. Early detection of streptococcal group antigens in skin samples by latex particle agglutination. Arch Dermatol. 1987 Apr;123(4):468-70. 摘要

10. Sachs MK. The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. Arch Intern Med. 1990 Sep;150(9):1907-12. 摘要

11. Duvanel T, Auckenthaler R, Rohner P, et al. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med. 1989 Feb;149(2):293-6. 摘要

12. Howe PM, Fajardo JE, Orcutt MA. Etiologic diagnosis of cellulitis: comparison of aspirates obtained from the leading edge and the point of maximal inflammation. Pediatr Infect Dis J. 1987 Jul;6(7):685-6. 摘要

13. Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. J Infect. 2012 Feb;64(2):148-55. 摘要

14. Chira S, Miller LG. Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review. Epidemiol Infect. 2010 Mar;138(3):313-7. 摘要

15. Hook EW 3rd, Hooton TM, Horton CA, et al. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986 Feb;146(2):295-7. 摘要

16. Baddour LM, Bisno AL. Recurrent cellulitis after coronary bypass surgery. JAMA. 1984 Feb 24;251(8):1049-52. 摘要

17. Kupper TS. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest. 1990 Dec;86(6):1783-9.全文  摘要

18. Okada N, Pentland AP, Falk P, et al. M Protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest. 1994 Sep;94(3):965-77.全文  摘要

19. Semel JD, Goldin H. Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. Clin Infect Dis. 1996 Nov;23(5):1162-4. 摘要

20. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.全文  摘要

21. National Institute for Health and Care Excellence. Cellulitis and erysipelas: antimicrobial prescribing. September 2019 [internet publication].全文

22. Edwards G, Freeman K, Llewelyn MJ, et al. What diagnostic strategies can help differentiate cellulitis from other causes of red legs in primary care? BMJ. 2020 Feb 12;368:m54. 摘要

23. Clinical Resource Efficiency Support Team. Guidelines on the management of cellulitis in adults. June 2005 [internet publication].全文

24. Morris A. Cellulitis and erysipelas. Clin Evid. 2004 Dec;(12):2271-7. 摘要

25. Phoenix G, Das S, Joshi M. Diagnosis and management of cellulitis. BMJ. 2012 Aug 7;345:e4955. 摘要

26. Morris AD. Cellulitis and erysipelas. BMJ Clin Evid. 2008 Jan 2;2008:1708.全文  摘要

27. National Institute for Health and Care Excellence. Sepsis: recognition, diagnosis and early management. September 2017 [internet publication].全文

28. NHS England. Sepsis guidance implementation advice for adults. September 2017 [internet publication].全文

29. Royal College of Physicians. National early warning score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. December 2017 [internet publication].全文

30. Sullivan T, de Barra E. Diagnosis and management of cellulitis. Clin Med (Lond). 2018 Mar;18(2):160-3.全文  摘要

31. Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.全文  摘要

32. Cross HH. Obtaining a wound swab culture specimen. Nursing. 2014 Jul;44(7):68-9.全文  摘要

33. Public Health England. UK standards for microbiology investigations: investigation of swabs from skin and superficial soft tissue infections. December 2018 [internet publication].全文

34. Inada-Kim M. Introducing the suspicion of sepsis insights dashboard. Royal College of Pathologists Bulletin. 2019 Apr;186;109.

35. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017 Mar;43(3):304-77.全文  摘要

36. Nutbeam T, Daniels R; The UK Sepsis Trust. Professional resources: clinical [internet publication].全文

37. Quirke M, Ayoub F, McCabe A, et al. Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis. Br J Dermatol. 2017 Aug;177(2):382-94. 摘要

38. Kloek CE, Rubin PA. Role of inflammation in orbital cellulitis. Int Ophthalmol Clin. 2006 Spring;46(2):57-68. 摘要

39. Rumelt S, Rubin PA. Potential sources for orbital cellulitis. Int Ophthalmol Clin. 1996 Summer;36(3):207-21. 摘要

40. Swift AC, Charlton G. Sinusitis and the acute orbit in children. J Laryngol Otol. 1990 Mar;104(3):213-6. 摘要

41. Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003 Nov;52 Suppl 1:i3-17.全文  摘要

42. Al Ghazal P, Körber A, Klode J, et al. Evaluation of the Essen Rotary as a new technique for bacterial swabs: results of a prospective controlled clinical investigation in 50 patients with chronic leg ulcers. Int Wound J. 2014 Feb;11(1):44-9. 摘要

43. Perl B, Gottehrer NP, Raveh D. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis. 1999 Dec;29(6):1483-8. 摘要

44. Newell PM, Norden CW. Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults. J Clin Microbiol. 1998 Mar;26(3):401-4.全文  摘要

45. Lebre C, Girard-Pipau F, Roujeau JC, et al. Value of fine-needle aspiration in infectious cellulitis. Arch Dermatol. 1996 Jul;132(7):842-3. 摘要

46. Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. Am J Roentgenol. 1998 Mar;170(3):615-20.全文  摘要

47. McHenry CR, Piotrowski JJ, Petrinic D. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg. 1995 May;221(5):558-63.全文  摘要

48. National Institute for Health and Care Excellence. Lyme disease. October 2018 [internet publication].全文

49. Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med. 2005 Jan 4;142(1):47-55. 摘要

50. Fitzpatrick TB, Johnson RA, Wolff K. Color atlas & synopsis of clinical dermatology: common and serious diseases. 4th ed. New York, NY: The McGraw-Hill Companies; 2001.

51. Aberer W, Konrad K, Wolff K. Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol. 1988 Jan;18(1 Pt 1):105-14. 摘要

52. Callen JP. Neutrophilic dermatoses. Dermatol Clin. 2002 Jul;20(3):409-19. 摘要

53. Rapini RP, Warner NB. Relapsing polychondritis. Clin Dermatol. 2006 Nov-Dec;24(6):482-5. 摘要

54. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002 Jun;61(6):2210-7.全文  摘要

55. Kirsner RS, Pardes JB, Eaglstein WH, et al. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol. 1993 Apr;28(4):623-7. 摘要

56. Bruun T, Oppegaard O, Hufthammer KO, et al. Early response in cellulitis: a prospective study of dynamics and predictors. Clin Infect Dis. 2016 Oct 15;63(8):1034-41.全文  摘要

57. Brindle R, Williams OM, Barton E, et al. Assessment of antibiotic treatment of cellulitis and erysipelas: a systematic review and meta-analysis. JAMA Dermatol. 2019 Jun 12;155(9):1033-40.全文  摘要

58. Public Health England. Antimicrobial stewardship: start smart – then focus. March 2015 [internet publication].全文

59. National Institute for Health and Care Excellence. Evidence review for cellulitis and erysipelas – antimicrobial prescribing. NICE guideline NG414 evidence review. September 2019 [internet publication].全文

60. National Institute for Health and Care Excellence. Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use. August 2015 [internet publication].全文

61. Department of Health and Social Care. Chief Medical Officer annual report 2011: antimicrobial resistance. March 2013 [internet publication].全文

62. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. March 2019 [internet publication].全文

63. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. March 2019 [internet publication].全文

64. Clinical Resource Efficiency Support Team. Guidelines on the management of cellulitis in adults. June 2005 [internet publication]全文

65. Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003 Nov;52 Suppl 1:i3-17全文  摘要

66. National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. Clinical guideline CG174. May 2017 [internet publication]全文

67. Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014 Dec;4(3-4):176-88全文  摘要

68. National Institute for Health and Care Excellence. Acute kidney injury: prevention, detection and management. December 2019 [internet publication]全文

69. Hsu CY, Ordoñez JD, Chertow GM, et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008 Apr 2;74(1):101-7全文  摘要

70. Law JP, Pickup L, Townend JN, et al. Anticoagulant strategies for the patient with chronic kidney disease. Clin Med (Lond). 2020 Mar;20(2):151-5全文  摘要

71. National Institute for Health and Care Excellence. Cellulitis and erysipelas: antimicrobial prescribing. September 2019 [internet publication]全文

72. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2018 [internet publication]全文

73. Chowdhury TA, Cheston H, Claydon A. Managing adults with diabetes in hospital during an acute illness. BMJ. 2017 Jun 22;357:j2551全文  摘要

74. Joint British Diabetes Societies for inpatient care. Glycaemic management during the inpatient enteral feeding of stroke patients with diabetes. November 2019 [internet publication]全文

75. Joint British Diabetes Societies for inpatient care. The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients. October 2014 [internet publication]全文

76. Joint British Diabetes Societies for inpatient care. Management of adults with diabetes undergoing surgery and elective procedures: Improving standards. Revised March 2016 [internet publication]全文

77. British National Formulary 77. Metformin hydrochloride. London: BMJ Group, RCPCH Publications Ltd and the Royal Pharmaceutical Society of Great Britain. July 2020全文

78. Medicines and Healthcare products Regulatory Agency. SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness. March 2020 [internet publication]全文

79. Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015 Jun 15;38(9):1687-93 摘要

80. Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults. 2nd ed. September 2013 [internet publication]全文

81. Grau AJ, Urbanek C, Palm F. Common infections and the risk of stroke. Nat Rev Neurol. 2010 Dec;6(12):681-94 摘要

82. Eigenbrodt ML, Rose KM, Couper DJ, et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke. 2000 Oct;31(10):2307-13 摘要

83. Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016 May 4;47(6):e98-169全文  摘要

84. Pendlebury ST, Klaus SP, Mather M, et al. Routine cognitive screening in older patients admitted to acute medicine: abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE. Age Ageing. 2015 Oct 13;44(6):1000-5全文  摘要

85. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972 Nov;1(4):233-8 摘要

86. The National Institute for Health and Clinical Excellence. Delirium: diagnosis, prevention and management. (CG103). March 2019 [internet publication]全文

87. The National Institute for Health and Clinical Excellence. Dementia: assessment, management and support for people living with dementia and their carers. June 2018 [internet publication]全文

88. Scottish Intercollegiate Guidelines Network. Risk reduction and management of delirium. March 2019 [internet publication]全文

89. Nova Scotia Health Authority. This is not my Mom. 2012 [internet publication]全文

90. Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med. 1999 May;106(5):565-73 摘要

91. Bellelli G, Morandi A, Davis DH, et al. Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people. Age Ageing. 2014 Mar 2;43(4):496-502全文  摘要

92. MacLullich AM, Shenkin SD, Goodacre S, et al. The 4 'A's test for detecting delirium in acute medical patients: a diagnostic accuracy study. Health Technol Assess. 2019 Aug;23(40):1-194全文  摘要

93. White S, Griffiths R, Baxter M, et al. Guidelines for the peri-operative care of people with dementia: guidelines from the Association of Anaesthetists. Anaesthesia. 2019 Jan 11;74(3):357-72全文  摘要

94. Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2016 Mar 11;3:CD005563全文  摘要

95. Martinez F, Tobar C, Hill N. Preventing delirium: should non-pharmacological, multicomponent interventions be used? A systematic review and meta-analysis of the literature. Age Ageing. 2014 Nov 25;44(2):196-204全文  摘要

96. Public Health England. Urinary tract infection: diagnostic tools for primary care. September 2019 [internet publication]全文

97. Pryor C, Clarke A. Nursing care for people with delirium superimposed on dementia. Nurs Older People. 2017 Mar 31;29(3):18-21全文  摘要

98. Ma H, Huang Y, Cong Z, et al. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials. J Alzheimers Dis. 2014;42(3):915-37 摘要

99. Huybrechts KF, Gerhard T, Crystal S, et al. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ. 2012 Feb 23;344:e977全文  摘要

100. Van Leeuwen E, Petrovic M, van Driel ML, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018 Mar 30;3:CD007726全文  摘要

101. Fritz Z, Slowther AM, Perkins GD. Resuscitation policy should focus on the patient, not the decision. BMJ. 2017 Feb 28;356:j813全文  摘要

102. National Institute for Health and Care Excellence. Decision making and mental capacity. October 2018 [internet publication]全文

103. Department of Health. Mental Capacity Act 2005 [internet publication]全文

104. Social Care Institute for Excellence. Independent mental capacity advocate (IMCA). 2011 [internet publication]全文

105. American Diabetes Association. 15. Diabetes care in the hospital: standards of medical care in diabetes - 2020. Diabetes Care. 2020 Jan;43(suppl 1):S193-S202全文  摘要

106. NHS Digital. National Diabetes Inpatient Audit (NaDIA) - 2017. March 2018 [internet publication]全文

107. Joint British Diabetes Societies for inpatient care. Self-management of diabetes in hospital. March 2012 [internet publication]全文

108. National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. July 2016 [internet publication]全文

109. Centre for Perioperative Care. Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery. March 2021 [internet publication]全文

110. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009 May-Jun;15(4):353-69 摘要

111. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67全文  摘要

112. NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.全文  摘要

113. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2009 Dec 16;137(3):544-51全文  摘要

114. Joint British Diabetes Societies for inpatient care. The management of the hyperosmolar hyperglycaemic state (HHS) in adults with diabetes. August 2012 [internet publication]全文

115. Rehman A, Setter SM, Vue MH. Drug-induced glucose alterations part 2: drug-Induced hyperglycemia. Diabetes Spect. 2011 Nov;24(4):234-8全文

116. Joint British Diabetes Societies for inpatient care. The hospital management of hypoglycaemia in adults with diabetes mellitus. 4th ed. January 2020 [internet publication]全文

117. Rowles S, Kilvert A, Sinclair A; on behalf of the Association of British Clinical Diabetologists (ABCD). ABCD position statement on diabetes and end of life care. Pract Diab Int, 2011;28:26-7全文

118. National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. October 2019 [internet publication]全文

119. Rayman G, Vas PR, Baker N, et al. The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care. 2011 May 18;34(7):1517-8全文  摘要

120. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. July 2019 [internet publication]全文

121. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004 Jun;125(6):2309-21全文  摘要

122. Au DH, Curtis JR, Every NR, et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest. 2002 Mar;121(3):846-51全文  摘要

123. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2020 [internet publication]全文

124. Walters JA, Tan DJ, White CJ, et al. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018 Mar 19;3:CD006897全文  摘要

125. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13 摘要

126. Boden JM, Fergusson DM. Alcohol and depression. Addiction. 2011 Mar 7;106(5):906-14全文  摘要

127. Cleare A, Pariante CM, Young AH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015 May 12;29(5):459-525全文  摘要

128. National Institute for Health and Care Excellence. Depression in adults with a chronic physical health problem: recognition and management. October 2009 [internet publication]全文

129. Taylor DM, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 13th edition. Chichester: Wiley-Blackwell; 2018

130. Flowers L. Nicotine replacement therapy. Am J Psychiatry Resid. 2016 Jun;11(6)4-7全文

131. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15(6):469-94

132. Oliveira P, Ribeiro J, Donato H, Madeira N. Smoking and antidepressants pharmacokinetics: a systematic review. Ann Gen Psychiatry. 2017;16:17全文  摘要

133. National Centre for smoking cessation and training. Smoking cessation and mental health. 2014 [internet publication].全文

134. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005 Mar 17;352(11):1112-20 摘要

135. Auerbach AD, Vittinghoff E, Maselli J, et al. Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. JAMA Intern Med. 2013 Jun 24;173(12):1075-81全文  摘要

136. National Institute for Health and Care Excellence. Liaison psychiatry. In: Emergency acute medical care in over 16s: service delivery and organisation. March 2018 [internet publication]全文

137. National Confidential Enquiry into Patient Outcome and Death (NCEPOD). Treat as one. Bridging the gap between mental and physical healthcare in general hospitals. 2017 [internet publication]全文

138. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000 Jul 24;160(14):2101-7 摘要

139. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009 Apr 6;190(7 suppl):S54-60 摘要

140. Prina AM, Cosco TD, Dening T, et al. The association between depressive symptoms in the community, non-psychiatric hospital admission and hospital outcomes: a systematic review. J Psychosom Res. 2014 Nov 8;78(1):25-33全文  摘要

141. World Health Organization. Excess mortality in persons with severe mental disorders. 2016 [internet publication]全文

142. National Institute for Health and Care Excellence. Smoking: acute, maternity and mental health services. Public health guideline [PH48]. November 2013 [internet publication]全文

内容使用需遵循免责声明